Epitope-specific impairment of production of antibody against merozoite surface glycoprotein 1 of Plasmodium falciparum in symptomatic patients with malaria

[1]  A. Holder,et al.  Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human Antibodies , 1997, The Journal of experimental medicine.

[2]  H. Bujard,et al.  Epitope analysis of human T-cell response to MSP-1 of Plasmodium falciparum in malaria-nonexposed individuals. , 1997, International archives of allergy and immunology.

[3]  A. Holder,et al.  Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection , 1996, Infection and immunity.

[4]  A. Holder,et al.  Human immune response to MSP-1. , 1996, Parasitology today.

[5]  A. Holder,et al.  Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. , 1996, The Journal of infectious diseases.

[6]  P. Barr,et al.  A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria , 1996, Infection and immunity.

[7]  B. Hogh.  Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children. , 1996, Scandinavian journal of infectious diseases. Supplementum.

[8]  E. Riley,et al.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass , 1995, Infection and Immunity.

[9]  J. Baird.  Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. , 1995, Parasitology today.

[10]  D. Kaslow,et al.  Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus Monkeys , 1995, Molecular medicine.

[11]  A. Holder,et al.  Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum , 1995, Infection and immunity.

[12]  A. Holder,et al.  Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro , 1994, Infection and immunity.

[13]  A. Holder,et al.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein , 1994, The Journal of experimental medicine.

[14]  P. Ambroise‐Thomas,et al.  Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso , 1993, Journal of clinical microbiology.

[15]  J. Cooper.  Merozoite surface antigen-I of plasmodium. , 1993, Parasitology today.

[16]  O. Doumbo,et al.  A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections , 1993, Infection and immunity.

[17]  A. Taylor-Robinson,et al.  Anti-malarial antibodies in twins. , 1993, Parasitology today.

[18]  A. Holder,et al.  Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (Pf MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity , 1992, Parasite immunology.

[19]  L. Cooper,et al.  Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. , 1992, Molecular and biochemical parasitology.

[20]  R. Frank.  Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support , 1992 .

[21]  D. Stüber,et al.  System for High-Level Production in Escherichia coli and Rapid Purification of Recombinant Proteins: Application to Epitope Mapping, Preparation of Antibodies, and Structure—Function Analysis , 1990 .

[22]  H. Bujard,et al.  Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum , 1989, Infection and immunity.

[23]  K. Tanabe,et al.  Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. , 1987, Journal of molecular biology.